Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704)

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|11|1663-1669

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.11, 2014-06, pp. : 1663-1669

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1128-1137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose‐finding and efficacy confirmation trial of the superselective intra‐arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose‐finding phase

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 3, 2018-03 ,pp. : 475-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non–small cell lung cancer (NSCLC)

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : 1321-1327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Trial of Gemcitabine Dose Escalation with Concurrent Radiotherapy for Patients with Locally Advanced Pancreatic Cancer

By  

Pancreatology, Vol. 10, Iss. 1, 2010-03 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2749-2756

John Wiley & Sons Inc

Access to resources Recommend Favorite